AG
BNTX icon

Artal Group’s BioNTech BNTX Stock Holding History

Artal Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-900,000
Closed -$98.3M – 150
2021
Q1 		$98.3M Sell
900,000
-100,000
-10% -$10.6M 1.74% 15
2020
Q4 		$81.5M Sell
1,000,000
-731,214
-42% -$71.8M 1.75% 15
2020
Q3 		$120M Sell
1,731,214
-268,786
-13% -$19.3M 2.91% 7
2020
Q2 		$133M Sell
2,000,000
-228,130
-10% -$11.4M 3.73% 4
2020
Q1 		$130M Sell
2,228,130
-400,000
-15% -$15.6M 5.5% 3
2019
Q4 		$89M Buy
+2,628,130
New +$58.9M 3.44% 8

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Artal Group's BNTX Position: Q2 2021 in Review

Artal Group sold out of BioNTech (BNTX) in Q2 2021, closing a stake of 900,000 shares — an estimated $98.3M sold.

Artal Group first reported a position in BNTX in Q4 2019 and held it in 6 quarters. The position peaked at $133M in Q2 2020. 284 funds tracked by Wall St. Rank hold BNTX as of Q2 2021.

  • Artal Group reported no remaining BioNTech position as of Q2 2021 after selling out during the quarter.
  • Artal Group sold 900,000 BioNTech shares in Q2 2021, an estimated $98.3M.
  • Artal Group first reported a position in BioNTech in Q4 2019 and held it in 6 quarters.
  • Artal Group's BioNTech position peaked at $133M in Q2 2020.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q2 2021.

Based on Artal Group's 13F filing for Q2 2021, filed 13 Aug 2021.